Latest News

Dermatologists embrace low-dose oral minoxidil as hair loss adjunctive therapy


 

Not a magic wand

Despite the increased profile and interest, oral minoxidil is not a cure-all, clinicians said.

“It’s important for patients to realize that hair loss can be complicated and there is no one magic wand,” said Dr. Simmons-O’Brien. Clinicians typically “are using several things to help encourage these follicular units to not miniaturize and disappear and create scars,” she said.

Dr. Friedman said he finds that patients have a hard time hearing that to continue to maintain growth, they have to take a medication for the rest of their life. “If you stop, you will have to start again,” he said.

Oral minoxidil, when used in combination with other therapies, will improve hair growth, said Dr. Goldberg. But it will not take someone back a decade, she said. “I try to temper expectations – promise a little and achieve more,” Dr. Goldberg said.

The study was independently supported. Dr. Smith and Dr. Jones report no relevant financial relationships. Dr. Simmons-O’Brien reports that she has received speaking fees from Isdin. Dr. McMichael disclosed relationships with Eli Lilly, Pfizer, Nutrafol, Revian, and UCB Pharma. Dr. Friedman, Dr. Goldberg, and Dr. Talakoub reported no disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Low-level light therapy cap shows subtle effects on CCCA
MDedge Dermatology
Sexual dysfunction, hair loss linked with long COVID
MDedge Dermatology
Review cautions against influencer-promoted hair-growth remedies
MDedge Dermatology
Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination
MDedge Dermatology
Expert shares tips on hair disorders and photoprotection for patients of color
MDedge Dermatology
Low-dose oral minoxidil for the treatment of alopecia
MDedge Dermatology
Uncombable hair syndrome: One gene, variants responsible for many cases
MDedge Dermatology
Expert calls for thoughtful approach to curbing costs in dermatology
MDedge Dermatology
Alopecia areata: Positive results reported for two investigational JAK inhibitors
MDedge Dermatology
The CROWNing Event on Hair Loss in Women of Color: A Framework for Advocacy and Community Engagement (FACE) Survey Analysis
MDedge Dermatology